State Of New Jersey Common Retirement Fund D sells 72,118 shares of CME Group Inc. (NASDAQ:CME)

State of New Jersey Common Pension Fund D reduced its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 35.3% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 132,256 shares of the financial services provider’s stock after selling 72,118 shares during the period. State of New Jersey Common Pension Fund D’s holdings in CME Group were worth $26,002,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CME. Vanguard Group Inc. raised its holdings in CME Group by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after purchasing an additional 215,044 shares during the last quarter. Capital International Investors boosted its stake in CME Group by 24.1% in the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after purchasing an additional 3,069,806 shares during the last quarter. Capital World Investors boosted its holdings in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after buying an additional 1,172,575 shares during the last quarter. Bank of New York Mellon Corp boosted its position in CME Group by 2.9% in the first quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock worth $1,462,678,000 after purchasing an additional 189,842 shares during the period. Finally, Parnassus Investments LLC grew its holdings in CME Group by 0.4% during the fourth quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock valued at $1,193,551,000 after purchasing an additional 23,583 shares during the last quarter. Institutional investors own 87.75% of the company’s shares.

Insider buying and selling

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC’s website. Company insiders own 0.30% of the company’s shares.

CME Group price performance

Shares of NASDAQ:CME opened at $217.30 on Friday. The firm has a market cap of $78.24 billion, a PE ratio of 24.72, a PEG ratio of 8.92 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02, and a debt-to-equity ratio of 0.10. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $223.80. The company’s 50-day moving average is $205.28 and its 200-day moving average is $207.69.

CME Group (NASDAQ:CME – Get Free Report ) last posted its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. In the same quarter last year, the company earned $2.30 per share. The company’s revenue was up 12.7% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, September 9. This represents a dividend of $4.60 on an annualized basis and a yield of 2.12%. CME Group’s payout ratio is currently 52.33%.

Analysts on Wall Street are forecasting an increase

CME has been the subject of several analyst reports. Barclays boosted their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and reduced their price target for the company from $212.00 to $177.00 in a report on Tuesday, September 3rd . JPMorgan Chase & Co. lifted their price objective on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Piper Sandler restated an “overweight” rating and set a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Finally, Deutsche Bank Aktiengesellschaft upped their target price on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $209.73, based on data from MarketBeat.

Read the latest stock report on the CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indices, foreign exchange, agricultural commodities, energy and metals, as well as fixed income and foreign exchange trading services.

Featured stories

Want to see what other hedge funds own CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for CME Group Inc. (NASDAQ:CME – Free Report).

Get daily news and reviews for CME Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.